A blog exploring pharmaceutical relationship marketing, emarketing and innovation with a focus on rare disorders.
SirenWired
The convergence of rare disease, digital communications, and pharmaceutical marketing communications

#SocPharm Tweetchat Transcript 8/24/2011

Posted by | 10:43pm on Wednesday, August 24, 2011

:
Welcome everyone to this week’s edition of the #socpharm tweetchat – we talk #pharma marketing & social media best practices.

:
Say hello & introduce yourself to the #socpharm group. I’m Eileen, work at Siren Interactive, focus on #rarediseases, passionate about both.

:
One of the #socpharm “rules” is that when someone mentions the FDA we r supposed to take a sip of our drink, whether water, wine or whatever

:
I’ve got a cold, so I’ll be sipping Niquil at #socpharm tonight :)

:
Hi all you #socpharm tweeps. Frieda Hernandez here from Siren Interactive where I focus on #raredisease #epharma #epatient #fdasm #socpharm

:
Joshua, Philadelphia. Will try to join in but will be in and out during chat. #socpharm

:
@ Welcome to #socpharm!

:
Stacy Burch, Sanofi #socpharm

:
hi all; will join for as long as i can tonight! #socpharm I focus on patients, positioning and marketing!

:
T1: FB pharma walls r open to comments. if you look at GSK baby comments http://t.co/WEZJhw9 u can c negatively. Inevitable? #socpharm

:
@: @: Thanks for joining us Ellen & Stacy. #socpharm

:
Glad to be here! I might be in and out, just to let you know. #socpharm

:
Think @ may have overestimated the “Flash mob” at @ page, Just 6 people #socpharm

:
@: So Sanofi are among the pharmacos who opened up FB comments on corp page. Can u share thinking? #socpharm

:
@: hopefully some of these negative comments will die down after the honeymoon stage? Don’t think we can focus on them.#socpharm

:
T1: Pfizer FB page had some of the same people commenting negatively. I think both set clear expectations around terms of use. #socpharm

:
IMHO, whenever you engage with people a percentage of that interaction will be negative. Inevitable, especially 4 a corp #socpharm #socpharm

:
@: Agree, think they’ll get bored and go away. #socpharm

:
Sanofi followed very similar process to GSK and Pfizer with clear expectations on TOU and Rules of engagement. #socpharm

:
@: T!: i do think it is a shame that many of the disease fb pages were closed down and only company ones remain… #socpharm

:
@: Yes, some people just didn’t want to understand that FDA makes rules not pharma. Definite personal agendas. #socpharm

:
@: I agree that it is a shame. They’re missing the greatest potential benefits of #socpharm

:
@: Still a few FB disease pages (couple 4 hemophilia) left. #socpharm

:
My fav is http://t.co/RlEdHAM where substantive convo happening – that’s what it’s all about! #socpharm

:
T2: @ survey on what docs do/don’t want to hear about at dinner mtgs: http://t.co/nzMyH7K Any surprises? #socpharm

:
Engagement may help re:some people just didnt want to understand that FDA makes rules not pharma. Definite personal agendas. #socpharm

:
@: any suggestions for correcting this perception? #socpharm

:
Agree; Like this! thanks for sharing lRT @: : My fav is http://t.co/NgkECMr where substantive convo happening – #socpharm

:
RT @: NEW #LinkedIn Group: #SocialMedia Law http://t.co/jWgHVTN #FINRA #HIPAA #SocPharm #SMLaw (Non-lawyers welcome)

:
@ Ongoing education. I worked in hospitals/physicians for years but didn’t know about fair balance until shift to pharma #socpharm

:
@ @ Suggestion: Educate about regs. People outside of pharma just don’t know/understand the restrictions #socpharm

:
Pharma needs to use easy to understand language & explain pharma regs. Will take repetition. #socpharm

:
Actually 27% of doctors saying they avoid medical meetings due to transparency reporting is pretty significant…@EileenOBrien: T2: #socpharm

:
Your mouth to the FDA’s ears! RT @: Pharma needs to use easy to understand language & explain pharma regs. #socpharm

:
@ By posting on facebook or do you recommend other methods/tools to educate? #socpharm

:
might consider use of video..@SanofiUS: @: By posting on facebook or do you recommend other methods/tools to educate? #socpharm

:
@ @ Good suggestion! Thanks #socpharm

:
@ @ Yes video would be an excellent approach, especially for pts w/lower literacy levels. #socpharm

:
So back to T2: The evergreen topic of insurance & reimbursement still popular with docs! #socpharm

:
T2: Sorry here’s the summary, didn’t realize you had to download it: http://t.co/W3RTtQc #socpharm

:
esp w growing use of biologics &specialty Rx, insurance & reimbursement import to docs &patients @: So back to T2: #socpharm

:
I do like the “stump the speaker” reco one doc had, the idea of panels w/great Q&A sessions sounds appealing. #socpharm

:
Agreed YouTube RT @: might consider use of video @: : @: By posting on FB or do u recommend other…? #socpharm

:
T3: Survey of journal ads found only 18% in compliance! How does that happen? #socpharm http://t.co/9gvyRa1

:
Video= leverage ur multi-lingual HCP’s to help articulate the message in the language of ur patient pop #socpharm

:
multi language versions of video don’t need 2cost fortune- unless ur ad agency pushes a $100k series of shoots (lke@ my old co #socpharm

:
T3: I don’t work in print, but certainly interactive ads are reviewed w/ a fine tooth come by med/legal/compliance. #socpharm

:
Have to step out. Good chat and thanks for the suggestions. #socpharm

:
T3-if tht’s true, that proves that moving on SM presence isn’t as risky.Even w/rules we still suck at promo compliance #socpharm

:
LOL! RT @: : T3-if thts true, proves that moving on SM isnt as risky.Even w/rules we still suck at promo compliance #socpharm

:
Regulations that, however well-intentioned, are too hard to understand and follow. #socpharm

:
T4: Merck using Greg Allman for Hep C awareness: http://t.co/Yf2rkr3 Effective role model? Use of celebrities still valuable? #socpharm

:
RT @: Tonight at 7 pm CST at #socpharm we’ll be talking @ survey of docs do/don’t like from #pharma dinners: http://t.co/nzMyH7K +other topx

:
T4- our research says Yes on celebrities, most of time. Surprise result=young Type1 Diabetics want Brett Michaels #socpharm

:
T4- Of course the parents of yng Type 1′s don’t want Brett Michaels #socpharm

:
@: WOW, that so fascinates me. We talked about Brett Michaels at seminar & two 20-30 yo women bloggers said yuck! #socpharm

:
@: t3: frighteningly low but if I remember, study reflects ads from a few yrs ago? #socpharm

:
Shocker, that’s why their kids do RT @: : T4- Of course the parents of yng Type 1s dont want Brett Michaels #socpharm

:
@: As always Ellen you r right! Ads were from Nov 2008. #socpharm

:
RT @: esp w growing use of biologics &specialty Rx, insurance & reimbursement import to docs &patients @: So back to T2: #socpharm

:
Think Nick Jonas would be the perfect fit – liked by parents & kids, assuming he doesn’t pull a Tiger Woods :) #socpharm

:
RT @: : Tonight at 7 pm CST at #socpharm we’ll be talking @ survey of docs do/don’t like from #pharma dinners: http://t.co/nzMyH7K +other topx

:
@: I agree on the 20-30 yo women on Brett. The sample was 12 to 24, 58% male. Maybe that drove overall score #socpharm

:
Agree RT @: : Think Nick Jonas would be perfect fit -liked by parents & kids, assuming he doesn’t pull a Tiger Woods :) #socpharm

:
Have to run- thanks to all! #socpharm

:
Before we go wanted to share speakers announced for #SXSH in Philly. Some of my favs: sxsh.org. #socpharm

:
Excited to c @ @ @ @ @ @ all speaking at #sxsh sxsh.org #socpharm

:
“@jonmrich: Some new Facebook features for Pharma and a video demo of how to use them. http://t.co/5cNltqU #hcsm #socpharm

:
Thanks everyone to joining in #socpharm tonight. I’ll let you know when I post the transcript. Good night.

About Eileen O'Brien

Eileen has more than 16 years of digital healthcare marketing experience. She is an opinion leader on social media and biopharma, and has been invited to speak at industry conferences and quoted in publications.

View other posts from Eileen

2 Pingbacks/Trackbacks

    25 August 2011 at 10:08pm
    Transcript from last night's ...
  • Eileen O'Brien
  • 25 August 2011 at 10:08pm
    RT @EileenOBrien: Transcript from ...
  • Wendy Blackburn
Siren Interactive
  • Siren Interactive
  • Rare Disease Relationship Marketing Experts
  • 626 West Jackson Blvd, Suite 100
  • Chicago, IL 60661
  • 312.204.6700
  • 866.502.6714 (Toll Free)
  • www.sireninteractive.com